Abortus RB51 Research Articles

Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis

Brucellosis is one of the most prevalent zoonotic diseases of worldwide distribution caused by the infection of genus Brucella. Live attenuated vaccines such as B. abortus S19, B. abortus RB51 and B. melitensis Rev1 are found most effective against brucellosis infection in animals, contriving a number of serious side effects and having chances to revert back into their active pathogenic form. In order to engineer a safe and effective vaccine candidate to be used in both animals and human, a recombinant subunit vaccine molecule comprising the truncated region of glucokinase (r-glk) gene from B. abortus S19 was cloned and expressed in Escherichia coli BL21DE3 host. Female BALB/c mice immunized with purified recombinant protein developed specific antibody titer of 1:64,000. The predominant IgG2a and IgG2b isotypes signified development of Th1 directed immune responses. In vitro cell cytotoxicity assay using anti-r-glk antibodies incubated with HeLa cells showed 81.20% and 78.5% cell viability against lethal challenge of B. abortus 544 and B. melitensis 16M, respectively. The lymphocyte proliferative assay indicated a higher splenic lymphocyte responses at 25μg/ml concentration of protein which implies the elevated development of memory immune responses. In contrast to control, the immunized group of mice intra-peritoneal (I.P.) challenged with B. abortus 544 were significantly protected with no signs of necrosis and vacuolization in their liver and spleen tissue. The elevated B-cell response associated with Th1 adopted immunity, significant in vitro cell viability as well as protection afforded in experimental animals after challenge, supplemented with histopathological analysis are suggestive of r-glk protein as a prospective candidate vaccine molecule against brucellosis.

Immunoproteomics of Brucella abortus RB51 as candidate antigens in serological diagnosis of brucellosis

The current brucellosis serodiagnostic assays are chiefly based on detecting anti-LPS (lipopolysaccharide) antibodies. However, cross-reaction with some gram-negative bacteria can occasionally induce due to similar O-polysaccharide (OPS) structure. Therefore, the aim of the present study was to identify new candidate antigens from Brucella abortus RB51, a mutant strain lacking the LPS portion, which might be valuable in brucellosis diagnosis. To detect potential antigens, immobilized pH gradients (IPG) strips with three ranges (pH 3–5.6, 4–7 and 6–11) were applied. After separating the insoluble proteins of B. abortus RB51 using two-dimensional electrophoresis (2-DE), their immunogenicity was evaluated by western blotting using four types of antisera – B. abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7-positive, and B. abortus-negative bovine sera. Among the several immunogenic spots, the spots showing specific reactivity with only the B. abortus-positive antisera, were considered as candidate antigens. Overall, eleven immuno-reactive proteins were identified, as follows: Cu/Zn superoxide dismutase, histidinol dehydrogenase, chaperonin DnaK, chaperonin GroES, beta-ketoadipyl CoA thiolase, two-component response regulator, the cell-division protein FtsZ, aldehyde dehydrogenase, 50s ribosomal protein L10 and invasion protein B. These selected highly immunogenic protein spots might be useful as alternative antigens for brucellosis and helpful in reducing the cross-reactivity.

Abortion and premature birth in cattle following vaccination withBrucella abortusstrain RB51

Brucella abortus RB51 is the vaccine strain currently licensed for immunizing cattle against brucellosis in the United States. Most cattle are vaccinated as heifer calves at 4-12 months of age. Adult cattle may be vaccinated in selected high-risk situations. Two herds of pregnant adult cattle in the brucellosis-endemic area of Wyoming were vaccinated with a standard label dose (1.0-3.4 × 10(10) organisms) of RB51. Reproductive losses in the vaccinated herds were 5.3% (herd A) and 0.6% (herd B) and included abortions, stillbirths, premature calves, and unbred cows (presumed early abortion). Brucella abortus was cultured from multiple tissues of aborted and premature calves (7/9), and from placenta. Isolates were identified as B. abortus strain RB51 by standard strain typing procedures and a species-specific polymerase chain reaction. Bronchopneumonia with intralesional bacteria and placentitis were observed microscopically. There was no evidence of involvement of other infectious or toxic causes of abortion. Producers, veterinarians, and laboratory staff should be alert to the risk of abortion when pregnant cattle are vaccinated with RB51, to potential human exposure, and to the importance of distinguishing field from vaccinal strains of B. abortus.

Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16)

The aims of the present study were (i) to assess the in vitro genetic stability of S19 and RB51 Brucella abortus vaccines strains and (ii) to evaluate the ability of multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) as a tool to be used in the quality control of live vaccines against brucellosis. Sixty-three batches of commercial S19 (n=53) and RB51 (n=10) vaccines, produced between 2006 and 2009, were used in this study. S19 and RB51 vaccines were obtained from, respectively, seven and two different manufacturers. Ten in vitro serial passages were performed on reference strains and on selected batches of commercial vaccines. All batches, reference strains and strains of serial passages were typed by the MLVA16. The results demonstrated that B. abortus S19 and RB51 vaccine strains are genetically stable and very homogeneous in their respective groups. Anyway, batches of S19 from one manufacturer and batches of RB51 from another presented genotypes distincts from the reference vaccine strains. In both cases, differences were found on locus Bruce07, which had addition of one repeat unit in the case of S19 batches and the deletion of one repeat unit in the case of RB51 batches. In summary, MLVA16 proved to be a molecular tool capable of discriminating small genomic variations and should be included in in vitro official tests.

Regulation of cytokine gene expression during Brucella abortus infection

Toll-like receptors (TLR) play a key role in antimicrobial host defense. Bacterial cell wall components and lipopolysaccharide (LPS) are recognized by macrophages via TLR, resulting in activation of professional antigen-presenting cells, initiation of acquired immune responses and further elimination of the invasive bacteria. TLR2 and TLR4 have been shown to recognize bacterial components. TLR2 is required for signaling by numerous ligands from gram-negative and gram-positive bacteria such as lipoteichoic acids, peptidoglycan and lipoproteins. In contrast, TLR4 fails to confer responsiveness to gram-positive bacteria and their components, but it is the main LPS signaling receptor. LPS is a major constituent of the outer membrane of gram-negative bacteria, such as Brucella, and is known to activate neutrophils, monocytes, macrophages, and other cell types to up-regulate expression of adhesion molecules and produce a number of pro- and anti-inflammatory cytokines. This study demonstrates that the attenuated strain Brucella abortusRB51 can stimulate cells through TLR4 and MyD88, resulting in NF-kB activation. The virulent strain B. abortus 2308 can also stimulate the cells by a MyD88-dependent pathway without involving either TLR4 or TLR2. It also induced NF-kB activation and nuclear translocation, suggesting that B. abortus RB51 induces activation of the proinflammatory response by a TLR4-dependent pathway with the subsequent NF-kB activation and nuclear translocation; nevertheless, the 2308 strain induced NF-kB nuclear translocation that was activated by an alternative pathway, different from that induced by TLR. Key words: Brucella abortus, RB51, TLR, NF-kB, transduction signals, cytokines.

Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis

Programmed cell death (PCD) can play a crucial role in tuning the immune response to microbial infection. Although PCD can occur in different forms, all are mediated by a family of proteases called caspases. Caspase-2 is the most conserved caspase, however, its function in cell death is ill-defined. Previously we demonstrated that live attenuated cattle vaccine strain Brucella abortus RB51 induces caspase-2-mediated and caspase-1-independent PCD of infected macrophages. We also discovered that rough attenuated B. suis strain VTRS1 induces a caspase-2-mediated and caspase-1-independent proinflammatory cell death in infected macrophages, which was tentatively coined “caspase-2-mediated pyroptosis”. However, the mechanism of caspase-2-mediated cell death pathway remained unclear. In this study, we found that caspase-2 mediated proinflammatory cell death of RB51-infected macrophages and regulated many genes in different PCD pathways. We show that the activation of proapoptotic caspases-3 and -8 was dependent upon caspase-2. Caspase-2 regulated mitochondrial cytochrome c release and TNFα production, both of which are known to activate caspase-3 and caspase-8, respectively. In addition to TNFα, RB51-induced caspase-1 and IL-1β production was also driven by caspase-2-mediated mitochondrial dysfunction. Interestingly, pore formation, a phenomenon commonly associated with caspase-1-mediated pyroptosis, occurred; however, unlike its role in S. typhimurium-induced pyroptosis, pore formation did not contribute to RB51-induced proinflammatory cell death. Our data suggest that caspase-2 acts as an initiator caspase that mediates a novel RB51-induced hybrid cell death that simulates but differs from typical non-proinflammatory apoptosis and caspase-1-mediated proinflammatory pyroptosis. The initiator role of the caspase-2-mediated cell death was also conserved in cellular stress-induced cell death of macrophages treated with etoposide, naphthalene, or anti-Fas. Caspase-2 also regulated caspase-3 and -8 activation, as well as cell death in macrophages treated with each of the three reagents. Taken together, our data has demonstrated that caspase-2 can play an important role in mediating a proinflammatory response and a hybrid cell death that demonstrates features of both apoptosis and pyroptosis.

Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice

It has been demonstrated that antibodies specific for O-PS antigen of Brucella smooth strains are involved in the protective immunity of brucellosis. Since the rough strain Brucella melitensis B115 was able to protect mice against wild Brucella strains brucellosis despite the lack of anti-OPS antibodies, in this study we evaluated the biological significance of antibodies induced by this strain, directed to antigens other than O-PS, passively tranferred to untreated mice prior to infection with Brucella abortus 2308 and B. melitensis 16M virulent strains. The protective ability of specific antisera collected from mice vaccinated with B. melitensis B115, B. abortus RB51 and B. abortus S19 strains was compared. The results indicated that antibodies induced by B115 were able to confer a satisfactory protection, especially against B. abortus 2308, similar to that conferred by the antiserum S19, while the RB51 antiserum was ineffective. These findings suggest that antibodies induced by B115 could act as opsonins as well as antibodies anti-O-PS, thus triggering more efficient internalization and degradation of bacteria within phagocytes. This is the first study assessing the efficacy of antibodies directed to antigens other than O-PS in the course of brucellosis infection.

Antigenic, Immunologic and Genetic Characterization of Rough Strains B.abortus RB51, B.melitensis B115 and B.melitensis B18

The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes have been identified involved in the synthesis of the three LPS components: lipid A, core and O-PS. Usually, Brucella strains devoid of O-PS (rough mutants) are less virulent than the wild type and do not induce undesirable interfering antibodies. Such of them proved to be protective against brucellosis in mice. Because of these favorable features, rough strains have been considered potential brucellosis vaccines. In this study, we evaluated the antigenic, immunologic and genetic characteristics of rough strains B.abortus RB51, B.melitensis B115 and B.melitensis B18. RB51 derived from B.abortus 2308 virulent strain and B115 is a natural rough strain in which the O-PS is present in the cytoplasm. B18 is a rough rifampin-resistan mutant isolated in our laboratory.The surface antigenicity of RB51, B115 and B18 was evaluated by testing their ability to bind antibodies induced by rough or smooth Brucella strains. The antibody response induced by each strain was evaluated in rabbits. Twenty-one genes, involved in the LPS-synthesis, were sequenced and compared with the B.melitensis 16M strain.The results indicated that RB51, B115 and B18 have differences in antigenicity, immunologic and genetic properties. Particularly, in B115 a nonsense mutation was detected in wzm gene, which could explain the intracellular localization of O-PS in this strain.Complementation studies to evaluate the precise role of each mutation in affecting Brucella morphology and its virulence, could provide useful information for the assessment of new, attenuated vaccines for brucellosis.

English

  The activation and nuclear translocation of NF-kB and the expression of the pro-inflammatory cytokine genes by macrophages infected with the attenuated Brucella abortus RB51 and virulent 2308 strains were evaluated. pIkBα and NF-kB were determined by immunoblot, and cytokines IFN-g and IL12 mRNA were determined by reverse transcriptase polymerase chain reaction (qPCR) and translocation of NF-kB protein to the nucleus was determined by electrophoretic mobility shift assay (EMSA). We demonstrate that the attenuated B. abortus RB51 strain stimulates cells resulting in NF-kB activation and nuclear translocation, during experimental infection in macrophages J774A.1 which induced a pro-inflammatory response producing IL-6, 12 TNF-s INF-g and iNOS. The virulent strain B. abortus 2308 also stimulated the cells but induced a p50 homodimer of NF-kB which is inactive. The p50 homodimer of NF-kB binds to DNA, and thus blocked the activation of pro-inflammatory cytokines genes. Therefore, an evasion mechanism of the strain 2308 is to produce an inactive homodimer of NF-kB which does not give rise to pro-inflammatory response to eliminate the bacteria.   Key words: Brucella abortus, RB51, 2308, NF-kB, transduction signals.

Epidemiological study of Brucellosis in cattle, immunized with Brucella abortus RB51 vaccine in endemic zones

In this study the behavior of the Brucella abortus RB51 vaccine was evaluated in bovine herds, with different prevalence of Brucellosis. A prospective longitudinal study was made, in two dairies, one of low prevalence (9%) with 538 cows, and the other of high prevalence (15%) with 612 cows. The cattle were vaccinated twice 90 days apart with RB51 at a dose of 1 × 10 9 cfu/ml. The monthly incidence was determined during 660 days of observation. In the low prevalence dairy, all positive animals were eliminated as soon as they were diagnosed as positive and in this herd the number of new cases decreased to less than 1% between days 120, and day 660. In the dairy with high prevalence, positive cows were not eliminate resulting in the herd increasing its incidence by the end of the first year. Once positive animals were eliminated the incidence diminishes by day 660 to less of 1%. The odds ratio (OR) in the group of cows with abortion history, in the low prevalence dairy, was of 4.5 (1.2; 16.6), in the dairy ranch with high prevalence it presented an OR of 3.6 (1.5; 8.5). The conclusion from this study was that in brucellosis endemic zones, vaccination with RB51 by itself is not enough to control disease. It is mandatory that the initial elimination of all positive cows at the time of vaccination, the continued elimination of all new positive animals be adhered to for long periods of time.

Comparative study of the immunobiological properties of live brucellosis vaccines

Findings from the comparative study of the immunobiological properties of live brucellosis vaccines in guinea pigs are presented in the article. Vaccines from strains Brucella abortus 19 (U.S.) and 82 (Russia), in the S and SR forms, respectively, exhibited the highest and most pronounced immunological efficacy, while vaccines from strains B. abortus 82-PS (in the RS form) and B. abortus RB-51 and 75/79-AB (in the R forms) exhibited the lowest. The live vaccine from strain B. abortus 82, together with a high immunological activity, possesses inagglutinogenic properties. The great advantage of this vaccine over the vaccine from strain B. abortus 19 is that after its use in animals the problem of the differential diagnosis of brucellosis becomes much simpler. The live vaccine from strain B. abortus 82 was adopted in veterinary practice in the Russian Federation; it is widely used for the targeted prevention of bovine brucellosis, but can also be used successfully for wild animals such as bison, deer, elk, and others.

The feasibility of using antigens prepared with rough Brucella strains for diagnosis of canine brucellosis.

Clinical diagnosis of canine brucellosis is not sensitive enough and a negative blood culture cannot rule out the disease. Indirect methods of serological testing such as agar gel immunodiffusion (AGID), rapid slide agglutination test (RSAT) and indirect enzyme linked immunoassay (IELISA) are preferred for routine diagnosis. Since Brucella canis shares antigenic components with the Brucella ovis and Brucella abortus RB51 strain, it would seem that either strain could be used as antigen. We present data on AGID and IELISA tests using the B. ovis antigen, RSAT and IELISA using the B. canis antigen and IELISA using the B. abortus RB51 antigen. The cut-off values were adjusted by the ROC analysis; the IELISA-B. ovis cut-off value was 23 (%P) and the IELISA-B. abortus RB51, 24 (%P), with 100% sensitivity and 98.8% specificity. RSAT detected 100% of positive cases, while AGID was less sensitive. The sera from dogs treated with antibiotic showed that %P correlated well with the clinical course. Sera from dogs presumptively infected with B. suis were negative in all tests performed with the rough Brucella strains. RSAT is a very sensitive screening test and IELISA-B. canis, B. ovis and B. abortus RB51 could be used as confirmatory tests, since they show good specificity and sensitivity.

Evaluation of Vaccination with Brucella abortus RB51 Strain in Herds Naturally Infected with Brucellosis in Productive Systems Found in Tropical Climate

Evaluation of Vaccination with Brucella abortus RB51 Strain in Herds Naturally Infected with Brucellosis in Productive Systems Found in Tropical Climate

Molecular typing for epidemiological evaluation of Brucella abortus and Brucella canis isolated in Korea

To investigate genotype relationships among regional groups of Brucella isolates, variable-number tandem-repeat (VNTR) analysis was conducted according to previously reported methods. Field strains of Brucella abortus and Brucella canis were isolated from 9 provinces in the Republic of Korea during the years 1996–2006 and each of the isolates was classified by eight loci of HOOF-Prints. On the basis of the alleles, the 33 B. abortus and 21 B. canis field strains were divided into 22 and 18 distinct genotypes, respectively. Phylogenetic cluster analysis of Brucella isolates could be discriminated with geographical region in the Republic of Korea. Simpson's diversity index values of B. abortus and B. canis isolates ranged from 0 to 0.85. The stability of each locus was determined with in vivo and in vitro experiments. After twenty passages in blood agar, the VNTR numbers of loci 1 and 7 in B. abortus isolates and loci 5, 7, and 8 in B. canis isolates changed. The same change of the VNTR numbers at loci 1 and 7 was observed with B. abortus RB51 strains isolated from vaccinated cattle for the in vivo experiment. Although B. canis and B. abortus isolates were discriminated to herd levels by the HOOF-Prints, this method needs further improvement for the high variable locus. This study represents the first epidemiological data of molecular typing of B. abortus and B. canis reported in Korea.

Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death

Inhalation is a common route for Brucella infection. We investigated whether Brucella species can invade and replicate within alveolar (A549) and bronchial (Calu-6 and 16HBE14o-) human epithelial cells. The number of adherent and intracellular bacteria was higher for rough strains ( Brucella canis and Brucella abortus RB51) than for smooth strains ( B. abortus 2308 and Brucella suis 1330). Only smooth strains exhibited efficient intracellular replication (1.5–3.5 log increase at 24 h p.i.). A B. abortus mutant with defective expression of the type IV secretion system did not replicate. B. abortus internalization was inhibited by specific inhibitors of microfilaments, microtubules and PI3-kinase activity. As assessed with fluorescent probes, B. abortus infection did not affect the viability of A549 and 16HBE14o- cells, but increased the percentage of injured cells (both strains) and dead cells (RB51) in Calu-6 cultures. LDH levels were increased in supernatants of Calu-6 and 16HBE14o- cells infected with B. abortus RB51, and to a lower extent in Calu-6 infected with B. abortus 2308. No apoptosis was detected by TUNEL upon infection with smooth or rough B. abortus. This study shows that smooth brucellae can infect and replicate in human respiratory epithelial cells inducing minimal or null cytotoxicity.

Brucella melitensisB115-based complement fixation test to detect antibodies induced byBrucellarough strains

To assess the efficiency of a Brucella melitensis B115 rough strain, naturally devoid of anticomplementary activity, used as antigen in a complement fixation test (CFT) to detect antibodies induced by Brucella strains with rough phenotype, such as Brucella abortus RB51, Brucella ovis and Brucella canis. Complement fixation testing was performed on sera from RB51-vaccinated cattle and buffaloes, B. ovis-infected sheep and B. canis-infected dogs using B115, RB51 and the hot saline extract (HSE) as antigens. The B115-based CFT proved highly sensitive and specific in detecting rough antibodies and its efficiency was comparable with that of RB51 and HSE-based CFT. Brucella melitensis B115 can be successfully used as an antigen in CFT to detect antibodies induced by Brucella rough strains. Brucella melitensis B115 antigen may represent an improvement over Brucella rough strains for Brucella antibody detection by CFT, thus enhancing the efficiency of brucellosis surveillance systems. Owing to the absence of anticomplementary activity, it does not require particular growth conditions or modifications and can be accurately standardized. The B115-based CFT may constitute a suitable supplementary test for the diagnosis of human infections owing to rough Brucellae.

Development of a multiplex polymerase chain reaction assay for differentiation of field strain isolates and vaccine strains S19 and RB51 of Brucella in Iran

Summary Bovine brucellosis is a zoonotic disease distributed worldwide and characterized by abortion and reduced fertility in cows. Since brucellosis eradication programme in Iran uses vaccination, test, slaughter and quarantine as control measures, it is essential to distinguish vaccine strains from strains that cause infections among vaccinated cattle herds. We developed and evaluated a multiplex polymerase chain reaction (PCR) assay to identify and differentiate the vaccine strains from wild field isolates, including all Brucella types usually found in cattle in Iran. Two pair primers were used to amplify eri and wbo regions of DNA sequences those strain-specific targets for B. abortus S19 and RB51 vaccine strains. This multiplex PCR method evaluated with DNA from reference strains, two vaccine strains and 29 field strains of Brucella. The results showed that the multiplex PCR can differentiate Brucella isolates into three categories: strain 19 (S19), strain RB51 and field strains. This PCR assay was successfully used, compared with traditional method to differentiate of S19 and RB51 from field Brucella isolates.

Update: Potential Exposures to Attenuated Vaccine Strain <emph type="ital">Brucella abortus</emph> RB51 During a Laboratory Proficiency Test—United States and Canada, 2007

In November 2007, New York State Department of Health (NYSDOH) officials notified CDC of potential exposures to attenuated vaccine strain Brucella abortus RB51 (RB51) in multiple clinical laboratories that participated in a Laboratory Preparedness Survey (LPS) proficiency test. NYSDOH conducted a survey of participating laboratories and identified 17 laboratories that reported handling the RB51 sample in a manner placing lab workers at potential risk for exposure. Subsequently, CDC recommended that public health officials conduct a review of biosafety practices at all LPS-participating laboratories to identify any additional RB51 exposures. This report summarizes the results of investigations in 36 states, two cities, one county, and the District of Columbia. As of January 14, 2008, follow-up by public health officials with LPS-participating laboratories throughout the United States identified a total of 916 laboratory workers in 254 laboratories with potential RB51 exposure. The results highlight the need for routine adherence to recommended biosafety practices when working with infectious organisms, particularly during widespread infectious-disease events, including bioterrorism attacks.

Demonstration of IS711 transposition in Brucella ovis and Brucella pinnipedialis

BackgroundThe Brucella genome contains an insertion sequence (IS) element called IS711 or IS6501, which is specific to the genus. The copy number of IS711 varies in the genome of the different Brucella species, ranging from 7 in B. abortus, B. melitensis and B. suis to more than 30 in B. ovis and in Brucella strains isolated from marine mammals. At present, there is no experimental evidence of transposition of IS711, but the occurrence of this element with a high copy number in some species, and the isolation of Brucella strains with "ectopic" copies of IS711 suggested that this IS could still transpose.ResultsIn this study we obtained evidence of transposition of IS711 from the B. ovis and B. pinnipedialis chromosomes by using the "transposon trap" plasmid pGBG1. This plasmid expresses resistance to tetracycline only if the repressor gene that it contains is inactivated. The strains B. melitensis 16 M, B. abortus RB51, B. ovis BOC22 (field strain) and B. pinnipedialis B2/94, all containing the plasmid pGBG1, were grown in culture media with tetracycline until the appearance of tetracycline resistant mutants (TcR). TcR mutants due to IS711 transposition were only detected in B. ovis and B. pinnipedialis strains.ConclusionFour different copies of IS711 were found to transpose to the same target sequence in the plasmid pGBG1. This demonstrated that IS711 are active in vivo, specially in Brucella species with a high number of IS711 copies as B. ovis and B. pinnipedialis.

Oral Vaccination and Immunocontraception of Feral Swine using Brucella suis with Multimeric GnRH Protein Expression

As part of the Reproductive Control Methods Project, the USDA National Wildlife Research Center (NWRC) has developed multiple non-lethal contraceptive tools to control population of over-abundant wildlife species. Working in conjunction with Dr. G. P. Talwar of the Talwar Research Institute in India, scientists at NWRC have shown that a recombinant form of GnRH peptide has successfully contracepted swine. Feral swine not only pose a significant agricultural issue due to over-population; they act as a reservoir for Brucella suis, a threat to domestic livestock and humans. The Brucella abortus RB51 (Rough Brucella) vaccine, developed for bovine brucellosis and licensed by the USDA Animal Plant Health Inspection Service, has shown protection for some swine and is also effective against Brucella suis infection and other antigens. There is currently no approved vaccine for swine brucellosis (feral or domestic) in the United States. Past studies performed at The Ohio State University show that Brucella suis vaccination appears to protect against abortion and colonization in pigs after a virulent challenge. The Talwar recombinant peptide consists of 5 LHRH peptides interspersed with 4 universally immunogenic “promiscuous” T-cell epitopes of diverse genetic background. By transforming the Brucella suis strain with the Talwar recombinant LHRH plasmid, the bacteria will produce both its own host proteins, and the LHRH protein. A systemic immune response should then be generated to the Brucella suis proteins being produced, allowing for vaccination to Brucella suis. In addition, an immune response would be generated to the LHRH proteins resulting in antibody production and immunocontraception. A broad range of applications can be proposed utilizing the recombinant LHRH, such as other dual vaccines and scale-up production of a low-cost single-injection LHRH vaccine.